[Medical treatment of circulatory insufficiency with special reference to cardiogenic shock syndromes].
D000818:Animals; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D012769:Shock / Q000209:etiology / Q000628:therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D014667:Vasopressins